Amorphical Ltd.

9 clinical trials · Sponsor

Record	Firm	Date
Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults (NCT06547151)	Amorphical Ltd.	2024-12-15
Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC (NCT02864784)	Amorphical Ltd.	2022-06-01
Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. (NCT04900337)	Amorphical Ltd.	2021-02-09

Every clearance here is in the API, with alerts when new ones post.